what does retatrutide and the Grey Market: Buyer Beware – Sarah Hormachea Retatrutide for weight loss: how

[March 6, 2025] The National Minority Quality Forum (NMQF) today announced the launch of its Health Not Hype campaign during Obesity Care Week to raise awareness about the growing public health risks associated with compounded GLP-1 medications and to help patients make informed decisions about obesity treatment

As of 2025, retatrutide is still in Phase 3 clinical trials

Safety checks align with general expectations

His own prescribing approach is conservative

Magnesium supplementation should be individualized based on laboratory results rather than routinely recommended, particularly in patients with kidney disease

van Ruiten CC, van der Aart-van der Beek AB, RG IJ, et al